In cancer patients, aberrant signalling via activin and/or its receptors can be linked with cancer progression including epithelial-to-mesenchymal transition, cancer cell migration and invasion and neo-angiogenesis during tumorigenesis [14]. This evidence concerns the gene INHBE and cancer.